Clinical Medicine
关注临床医学

影响因子已更新

Taylor & Francis 旗下的医学与健康期领域拥有近400本相关期刊,涵盖免疫学、肿瘤医学、药学、神经学、生物学、全科医学、医学教育学等多个领域,关注基础、转化和临床的各个阶段优质研究成果。其中,超过100本期刊致力于发表临床医学实践中的创新发现、实战经验、深度理论探索和典型病例解析等内容,95%已获得影响因子!超70%已被SCI(科学引文索引)或SSCI(社会科学引文索引)权威收录!

重点学科 & 期刊列表

Journal of Hepatocellular Carcinoma
Impact Factor: 4.1 (2022)
Q2

Publishes open access research on hepatocellular carcinoma, focusing on signaling pathways, tumor classification, radiology, drug treatment and epidemiology.

View journal
International Journal of Hyperthermia
Impact Factor: 3.1 (2022)
Q2
Publishes articles on various aspects of thermal energy and thermal therapy in clinical, biological or engineering studies involving human or animals.
View journal
OncoTargets and Therapy
Impact Factor: 4.0 (2022)
Q2

Publishes open access molecular research on all types of cancer, including therapeutic targets and regimens, diagnosis, pathology, and novel treatments.

View journal
Cancer Investigation
Impact Factor: 2.4 (2022)
Publishes original papers, essays, reports on new technologies, and reviews in the fields of translational and clinical oncology.It offers accelerated publication.
View journal

Dialogues in Clinical Neuroscience
Impact Factor: 8.3 (2022)
Q1
Open Access journal publishing at the interface between clinical neuropsychiatry and the neurosciences focussing on relevant clinical, biological, and therapeutic aspects.
View journal
Nature and Science of Sleep
Impact Factor: 3.4 (2022)
Q2

Publishes open access research on the neurophysiology and functions of sleep, the genetics of sleep, biological rhythms, dreaming, sleep disorders and therapy.

View journal
Expert Review of Neurotherapeutics
Impact Factor: 4.3 (2022)
Q2
A MEDLINE-indexed journal providing expert commentary on the use of drugs and medicines in clinical neurology and neuropsychiatry. It offers accelerated publication.
View journal
Behavioral Sleep Medicine
Impact Factor: 3.1 (2022)
Focuses on sleep disorders, sleep-related symptoms, insomnia and associated behavioural, cognitive, emotional, physiological and mental health problems.
View journal

Climacteric
Impact Factor: 2.8 (2022)
Q2
Climacteric publishes research into menopause, climacteric and mid-life health, including counselling and education of peri- and post- menopausal women. 
View journal
Journal of Psychosomatic Obstetrics & Gynecology
Impact Factor: 3.1 (2022)
Q2
Focuses on psychosomatic and psychosocial aspects of women’s health in various disciplines such as gynecology, obstetrics, nursing, psychiatry and psychology.
View journal

International Journal of Audiology
Impact Factor: 2.7 (2022)
Q1
An international journal publishing research into audiology and hearing sciences including psychoacoustics, hearing impairment and rehabilitation devices. 
View journal
Clinical, Cosmetic and Investigational Dentistry
Impact Factor: 1.8 (2022)
Publishes open access research on dentistry, focusing on cosmetic intervention, including novel materials, techniques and devices, surgery, and orthodontics.

 

View journal
Clinical and Experimental Optometry
Impact Factor: 1.9 (2022)
Publishes research in optometry and vision science, including clinical refraction, spectacle and contact lenses, eye disease, and ocular therapeutics.
View journal

Psychology Research and Behavior Management
Impact Factor: 4.3 (2022)
Q1

Publishes open access research on behavioral, cognitive and social neuroscience, psychophysiology, behavior management and learning.

View journal
International Journal of Psychiatry in Clinical Practice
Impact Factor: 3.0 (2022)
Focuses on mental health, neuropsychopharmacology, neuropsychiatry, clinical neurophysiology, psychotherapy, addiction, depression, anxiety and schizophrenia.
View journal
Psychology, Health & Medicine
Impact Factor: 3.8 (2022)
Q2
Publishes research on human factors in health and illness, biopsychosocial approaches to medical care and management, and psychology and health in practice.
View journal
Journal of Psychoactive Drugs
Impact Factor: 2.8 (2022)
Q2
Focuses on drug abuse, dependence, addiction, rehabilitation and research, hallucinogens, psychotherapy and counseling of individuals and families.
View journal

Critical Reviews in Clinical Laboratory Sciences
Impact Factor: 10.0 (2022)
Q1
Publishes reviews on clinical laboratory aspects of biochemistry, microbiology, pathology, transfusion medicine, genetics, immunology and molecular diagnostics.
View journal
Biomarkers
Impact Factor: 2.6 (2022)
Accepts studies on humans/animals on biomarkers of disease, exposure, response and susceptibility, focusing on relationships between markers and effects. It offers accelerated publication.
View journal

Expert Review of Clinical Immunology
Impact Factor: 4.4 (2022)
Q2
A MEDLINE-indexed, peer-reviewed journal providing the latest research on the performance of new therapeutic and diagnostic modalities in clinical immunology. This journal offers accelerated publication.
View journal
Clinical Epidemiology
Impact Factor: 3.9 (2022)
Q2

Publishes open access research on epidemiology and clinical care, including electronic records, data-gathering, diagnostic procedures and predictive markers.

View journal
Immunological Medicine
Impact Factor: 4.4 (2022)
Advances in the field of clinical immunology including autoimmune and infectious diseases that require immunological approaches from various medical fields.
View journal
The European Journal of General Practice
Impact Factor: 3.4 (2022)
Q1
Publishes open access research on medical decision-making, healthcare delivery, medical education, and research methodology for primary care practice.
View journal

医学与健康及其他各学科高水平国际期刊,请访问 Taylor & Francis Group 旗下学术期刊网站, 欢迎相关学科研究人员向您青睐的杂志投稿。

期刊网站:www.tandfonline.com

banner

选择加速出版

如果时间对于您至关重要,我们部分医学与健康及药学期刊提供加速出版服务。我们将通过投入额外的资源来监控和管理同行评审流程,满足紧迫的周转时间要求,帮助您快速发表研究成果。

Author Services Button

为期刊、图书作者提供的实用指南

在您准备撰写一篇国际学术论文时,一个为您提供必要指导和资源实用网站可以为您解答许多疑问!从选刊、写作、投稿、同行评审、出版等各个方面给予详细的指导,写作投稿前的必看网站!

Choose Open.

拥抱开放科学

开放获取对于作者、读者而言极具价值,开放科学让研究在更广泛的维度得到参考和使用,提升研究可见度和影响力,造福社会。您是否考虑发表开放获取文章?点击了解开放获取出版更多信息